Literature DB >> 19233577

A case of Ohtahara syndrome with mitochondrial respiratory chain complex I deficiency.

Joo Hee Seo1, Young Mock Lee, Joon Soo Lee, Se Hoon Kim, Heung Dong Kim.   

Abstract

Ohtahara syndrome (OS) is known as an intractable epileptic syndrome in neonatal and early infantile period, differentiated from early myoclonic encephalopathy (EME) in its etiology. We report a patient with OS associated with mitochondrial respiratory chain complex (MRC) I defect. With ketogenic diet and mitochondrial cocktail therapy, seizures were completely controlled and suppression-burst patterns disappeared 3 months after starting treatment. It is suggested that OS could be caused by specific metabolic disorder such as MRC defect and the intensive therapies including ketogenic diet, vitamin and coenzyme therapy and antioxidant treatment might be helpful for some patients.

Entities:  

Mesh:

Year:  2009        PMID: 19233577     DOI: 10.1016/j.braindev.2008.12.020

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  12 in total

Review 1.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

2.  Brain ketones detected by proton magnetic resonance spectroscopy in an infant with Ohtahara syndrome treated with ketogenic diet.

Authors:  Kim M Cecil; Sarah B Mulkey; Xiawei Ou; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2014-06-08

Review 3.  Mitochondria and neonatal epileptic encephalopathies with suppression burst.

Authors:  Florence Molinari
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

4.  A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Authors:  David N Ruskin; Jessica L Ross; Masahito Kawamura; Tiffany L Ruiz; Jonathan D Geiger; Susan A Masino
Journal:  Physiol Behav       Date:  2011-04-09

Review 5.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

Review 6.  Emerging role of the KCNT1 Slack channel in intellectual disability.

Authors:  Grace E Kim; Leonard K Kaczmarek
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

7.  The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

Authors:  Marta Kanabus; Elisa Fassone; Sean David Hughes; Sara Farahi Bilooei; Tricia Rutherford; Maura O' Donnell; Simon J R Heales; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2016-04-14       Impact factor: 4.982

Review 8.  Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders.

Authors:  Eleni Paleologou; Naila Ismayilova; Maria Kinali
Journal:  J Clin Med       Date:  2017-05-26       Impact factor: 4.241

9.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

Review 10.  Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety.

Authors:  Heidi Zweers; Annemiek M J van Wegberg; Mirian C H Janssen; Saskia B Wortmann
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.